Anti-Toxoplasma gondii antibodies in patients with schizophrenia-preliminary findings in a Turkish sample

Creative Commons License

Cetinkaya Z., Yazar S., Gecici O., Namli M. N.

SCHIZOPHRENIA BULLETIN, cilt.33, sa.3, ss.789-791, 2007 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 33 Sayı: 3
  • Basım Tarihi: 2007
  • Doi Numarası: 10.1093/schbul/sbm021
  • Dergi Adı: SCHIZOPHRENIA BULLETIN
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Social Sciences Citation Index (SSCI), Scopus
  • Sayfa Sayıları: ss.789-791
  • Erciyes Üniversitesi Adresli: Evet

Özet

Schizophrenia is a serious neuropsychiatric disease of uncertain etiology. We investigated the seropositivity rate for anti-Toxoplasma IgG and IgNI antibodies by enzymelinked immunosorbent assay (ELISA) in patients with schizophrenia to ascertain a possible relationship between Toxoplasma gondii and schizophrenia. We selected 100 patients with schizophrenia, 50 with depressive disorder, and 50 healthy volunteers to investigate the seropositivity rate of anti-Toxoplasma antibodies by ELISA. The seropositivity rate for anti-Toxoplasma IgG antibodies among schizophrenia patients (66%) was significantly higher than among patients with depressive disorder or healthy volunteers (P <.01). Thus, there might be a causal relationship between toxoplasmosis and the etiology of schizophrenia.